We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
+19.07%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$1.44B
AUM Growth
+$344M
(+31%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
11.87%
Top 10 Holdings %
Top 10 Hldgs %
38.33%
Holding
267
New
32
Increased
87
Reduced
92
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Preferred Securities and Income ETF
FPE
|
+$65.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$55.9M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$55.4M |
| 4 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$46.3M |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$144M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$72.2M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$16.3M |
| 4 |
VanEck High Yield Muni ETF
HYD
|
+$12.4M |
| 5 |
RTN
Raytheon Company
RTN
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.17% |
| 2 | Technology | 12.57% |
| 3 | Healthcare | 7.87% |
| 4 | Industrials | 4.96% |
| 5 | Financials | 4.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
| $3.73M | 0.26% |
153,158
+91,462
| +148% | +$2.08M |
|
77
John Hancock Multifactor Mid Cap ETF
JHMM
$5.9B
| $3.52M | 0.24% |
100,326
-885
| -0.9% | -$29.1K |
|
78
Berkshire Hathaway Class B
BRK.B
$1.11T
| $3.44M | 0.24% |
19,294
-1,724
| -8% | -$315K |
|
79
iShares Russell 2000 ETF
IWM
$76.5B
| $3.39M | 0.24% |
23,682
+2,008
| +9% | +$263K |
|
80
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $3.35M | 0.23% |
83,843
-564
| -0.7% | -$21.1K |
|
81
ExxonMobil
XOM
$672B
| $3.31M | 0.23% |
73,962
+419
| +0.6% | +$18.8K |
|
82
KLA
KLAC
$219B
| $3.24M | 0.23% |
166,500
-20,040
| -11% | -$343K |
|
83
Chevron
CVX
$415B
| $3.1M | 0.22% |
34,770
+1,287
| +4% | +$115K |
|
84
PepsiCo
PEP
$183B
| $3.08M | 0.21% |
23,310
-1,095
| -4% | -$144K |
|
85
Comcast
CMCSA
$84.2B
| $3.07M | 0.21% |
78,676
+4,433
| +6% | +$169K |
|
86
Vanguard FTSE Developed Markets ETF
VEA
$233B
| $3.02M | 0.21% |
77,722
-4,330
| -5% | -$158K |
|
87
Procter & Gamble
PG
$341B
| $2.92M | 0.2% |
24,449
-99
| -0.4% | -$11.5K |
|
88
Invesco Senior Loan ETF
BKLN
$6.78B
| $2.88M | 0.2% |
134,855
+16,407
| +14% | +$347K |
|
89
Eaton
ETN
$155B
| $2.82M | 0.2% |
32,218
+422
| +1% | +$34.7K |
|
90
SLB Ltd
SLB
$77.6B
| $2.62M | 0.18% |
142,622
+17,067
| +14% | +$299K |
|
91
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $2.57M | 0.18% |
64,813
-954
| -1% | -$35.3K |
|
92
McDonald's
MCD
$176B
| $2.49M | 0.17% |
13,516
+9
| +0.1% | +$1.65K |
|
93
Schwab US Large- Cap ETF
SCHX
$73B
| $2.48M | 0.17% |
200,892
+3,738
| +2% | +$43.6K |
|
94
Pfizer
PFE
$157B
| $2.44M | 0.17% |
78,761
+98
| +0.1% | +$3.33K |
|
95
Mastercard
MA
$497B
| $2.28M | 0.16% |
7,714
-361
| -4% | -$102K |
|
96
Broadcom
AVGO
$1.62T
| $2.22M | 0.15% |
70,390
+1,430
| +2% | +$40K |
|
97
IBM
IBM
$224B
| $2.13M | 0.15% |
18,417
-8,805
| -32% | -$1.02M |
|
98
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
| $1.92M | 0.13% |
9,608
| – | – |
|
99
MSC Industrial Direct
MSM
$6.73B
| $1.91M | 0.13% |
26,278
-1,714
| -6% | -$110K |
|
|
100
iShares 0-1 Year Treasury Bond ETF
SHV
$21.1B
| $1.71M | 0.12% |
15,397
-1,300,727
| -99% | -$144M |
|
Similar funds
CW
F
TYCC
AT
CCA
AF
FLSM
BT
Grimes & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Grimes & Company held 267 positions worth $1.44B, up 31% from $1.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Grimes & Company deployed $171M of net new capital in Q2 2020, opening 32 new positions and adding to 87 existing holdings. Its largest new stake was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $144M trimmed.
- Grimes & Company's largest Q2 2020 buy was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
- Grimes & Company added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $55.9M increase.
- Grimes & Company's biggest Q2 2020 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $144M.
- Grimes & Company fully exited VanEck High Yield Muni ETF in Q2 2020, selling an estimated $12.4M.
- Grimes & Company's ten largest holdings make up 38% of its $1.44B portfolio in Q2 2020.
- Grimes & Company opened 32 new positions and closed 18 in Q2 2020.
- Grimes & Company's portfolio value rose 31% quarter-over-quarter to $1.44B.
Based on Grimes & Company's 13F filing for Q2 2020, filed 31 Jul 2020.